
April 11, 2016 Medical Communications, Research and Development Bristol-Myers Squibb, Gilead, HIV, anti-HIV

April 11, 2016 Research and Development Epidiolex, GW Pharmaceuticals, Tuberous Sclerosis Complex, genetics, rare disease

April 11, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Index, Movers, markets, stocks

April 11, 2016 Business Services, Research and Development, Sales and Marketing Roche, US FDA, atezolizumab, lung cancer

April 11, 2016 Research and Development, Sales and Marketing chemotherapy, midatech, nausea, oncology, radiation, vomiting

April 11, 2016 Research and Development, Sales and Marketing FDA, Sun Pharma, bromsite, ocular treatment

April 8, 2016 Research and Development HIV, crispr, failure, setback

April 8, 2016 Medical Communications, Research and Development, Sales and Marketing Intercept Pharmaceuticals, PDUFA, US FDA, liver disorder, rare disease

April 8, 2016 Manufacturing and Production, Research and Development 000 genomics project, 100, NHS, UK, expertise, genomics, international gathering, world leader
April 8, 2016 Medical Communications, Research and Development Parkinson's disease, Pfizer, collaboration, ibm, research, technology
April 8, 2016 Medical Communications, Research and Development, Sales and Marketing

April 8, 2016 Medical Communications, Research and Development Sandoz, binocrit, biosimilar, eu approval

April 7, 2016 Business Services, Research and Development, Sales and Marketing Boehringer Ingelheim, European Commission, giotrif, lung cancer

April 7, 2016 Medical Communications, Research and Development MedImmune, cancer research institute, clinical trial, ludwig, ovarian cancer, ventirx

April 7, 2016 Research and Development, Sales and Marketing Eli Lilly, Incyte, Licencing, M&A, MA, Novartis